• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Detection of Urinary Molecular Marker Test in Urothelial Cell Carcinoma: A Review of Methods and Accuracy.尿路上皮细胞癌中尿分子标志物检测:方法与准确性综述
Diagnostics (Basel). 2022 Nov 4;12(11):2696. doi: 10.3390/diagnostics12112696.
2
A review on the accuracy of bladder cancer detection methods.膀胱癌检测方法准确性综述。
J Cancer. 2019 Jul 8;10(17):4038-4044. doi: 10.7150/jca.28989. eCollection 2019.
3
Defining the role of NMP22 in bladder cancer surveillance.确定NMP22在膀胱癌监测中的作用。
World J Urol. 2008 Feb;26(1):51-8. doi: 10.1007/s00345-007-0226-z. Epub 2007 Dec 4.
4
Urine markers for detection and surveillance of bladder cancer.用于膀胱癌检测和监测的尿液标志物。
Urol Oncol. 2014 Apr;32(3):222-9. doi: 10.1016/j.urolonc.2013.06.001. Epub 2013 Sep 17.
5
Pathological possibilities and pitfalls in detecting aggressive bladder cancer.检测侵袭性膀胱癌的病理可能性和陷阱。
Curr Opin Urol. 2012 Sep;22(5):397-404. doi: 10.1097/MOU.0b013e328356ade6.
6
[Tumor marker tests in bladder cancer].[膀胱癌中的肿瘤标志物检测]
Actas Urol Esp. 2006 Jan;30(1):38-45. doi: 10.1016/s0210-4806(06)73394-0.
7
Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients.日本医院患者单一社区中UroVysion荧光原位杂交技术对膀胱癌诊断准确性的检测
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1271-1273. doi: 10.31557/APJCP.2019.20.4.1271.
8
Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.核基质蛋白、纤连蛋白、膀胱癌抗原及晨尿细胞学检查在膀胱肿瘤检测中的比较评估
J Urol. 2002 Aug;168(2):465-9.
9
[Diagnostic significance of protein NMP22 in bladder cancer].[蛋白质NMP22在膀胱癌中的诊断意义]
Pol Merkur Lekarski. 2015 Jun;38(228):309-14.
10
Comparison of the monoclonal UBC-ELISA test and the NMP22 ELISA test for the detection of urothelial cell carcinoma of the bladder.用于检测膀胱尿路上皮癌的单克隆UBC-ELISA试验与NMP22 ELISA试验的比较。
Urology. 2000 Feb;55(2):223-6. doi: 10.1016/s0090-4295(99)00383-0.

引用本文的文献

1
Untargeted urinary metabolomics for bladder cancer biomarker screening with ultrahigh-resolution mass spectrometry.基于超高分辨质谱的膀胱癌生物标志物筛选的非靶向性尿液代谢组学。
Sci Rep. 2023 Jun 16;13(1):9802. doi: 10.1038/s41598-023-36874-y.
2
Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer.肌层浸润性膀胱癌围手术期治疗的现状与未来前景
Cancers (Basel). 2023 Jan 17;15(3):566. doi: 10.3390/cancers15030566.

本文引用的文献

1
The Development of Non-Invasive Diagnostic Tools in Bladder Cancer.膀胱癌无创诊断工具的发展
Onco Targets Ther. 2022 May 2;15:497-507. doi: 10.2147/OTT.S283891. eCollection 2022.
2
Liquid biopsy in bladder cancer: State of the art and future perspectives.膀胱癌的液体活检:现状与未来展望。
Crit Rev Oncol Hematol. 2022 Feb;170:103577. doi: 10.1016/j.critrevonc.2022.103577. Epub 2022 Jan 5.
3
Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions.膀胱癌的微卫星不稳定性分析(MSA):过去的历史和未来的方向。
Int J Mol Sci. 2021 Nov 28;22(23):12864. doi: 10.3390/ijms222312864.
4
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).欧洲泌尿外科学会非肌层浸润性膀胱癌(Ta、T1和原位癌)指南
Eur Urol. 2022 Jan;81(1):75-94. doi: 10.1016/j.eururo.2021.08.010. Epub 2021 Sep 10.
5
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.烟酰胺 N-甲基转移酶作为一种潜在的生物标志物预测泌尿系统癌症的肿瘤学预后的效用:更新。
Biomolecules. 2021 Aug 16;11(8):1214. doi: 10.3390/biom11081214.
6
UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives.尿路上皮癌中的UroVysion荧光原位杂交:一篇叙述性综述及未来展望
Transl Androl Urol. 2021 Apr;10(4):1908-1917. doi: 10.21037/tau-20-1207.
7
Microsatellite instability in Gastric Cancer: Between lights and shadows.胃癌中的微卫星不稳定性:在光明与阴影之间。
Cancer Treat Rev. 2021 Apr;95:102175. doi: 10.1016/j.ctrv.2021.102175. Epub 2021 Mar 1.
8
Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer.免疫治疗时代的膀胱癌改变。
Front Immunol. 2020 Nov 5;11:575258. doi: 10.3389/fimmu.2020.575258. eCollection 2020.
9
Evaluation of UroVysion for Urachal Carcinoma Detection.UroVysion用于脐尿管癌检测的评估。
Front Med (Lausanne). 2020 Aug 27;7:437. doi: 10.3389/fmed.2020.00437. eCollection 2020.
10
Urinary biomarkers in bladder cancer: A review of the current landscape and future directions.膀胱癌的尿生物标志物:当前研究现状及未来方向综述。
Urol Oncol. 2021 Jan;39(1):41-51. doi: 10.1016/j.urolonc.2020.08.016. Epub 2020 Sep 9.

尿路上皮细胞癌中尿分子标志物检测:方法与准确性综述

Detection of Urinary Molecular Marker Test in Urothelial Cell Carcinoma: A Review of Methods and Accuracy.

作者信息

Bulai Catalin, Geavlete Petrisor, Ene Cosmin-Victor, Bulai Isabela, Popescu Razvan-Ionut, Mares Cristian, Ene Corina Daniela, Punga Ana-Maria, Geavlete Bogdan

机构信息

Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

"Saint John" Emergency Clinical Hospital, 042122 Bucharest, Romania.

出版信息

Diagnostics (Basel). 2022 Nov 4;12(11):2696. doi: 10.3390/diagnostics12112696.

DOI:10.3390/diagnostics12112696
PMID:36359539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9689047/
Abstract

Early detection of bladder cancer has a positive impact on prognosis. A variety of biomarkers have been developed to detect bladder tumors in urine early and reduce the need for cystoscopy. To detect bladder cancer, several methods are available, but their accuracy varies according to the sensitivity and specificity of each method. This review aims to highlight the established detection methods for bladder cancer based on the available literature. In addition, we aim to identify the combination of different effective detection methods that provides the highest degree of accuracy. In our study, a keyword retrieval method was used to search for appropriate English-language references. This bibliography has been indexed in PubMed and Scopus or has been found through systematic searches from 2015 to 2022. Based on an analysis of international guidelines, it has been revealed that there are numerous discrepancies and unresolved issues. The discovery of an ideal detection method for urothelial cell carcinoma biomarkers has been the subject of numerous efforts. In recent years, a wide range of off-label, experimental, novel, and combined approaches have been published on this topic. This review can contribute to the identification of accurate methods of detecting bladder cancer and highlight areas for future research that can be improved.

摘要

膀胱癌的早期检测对预后有积极影响。已经开发出多种生物标志物来早期检测尿液中的膀胱肿瘤,并减少膀胱镜检查的需求。为了检测膀胱癌,有几种方法可供选择,但它们的准确性根据每种方法的敏感性和特异性而有所不同。本综述旨在根据现有文献突出已确立的膀胱癌检测方法。此外,我们旨在确定能提供最高准确度的不同有效检测方法的组合。在我们的研究中,使用关键词检索方法来搜索合适的英文参考文献。该参考文献已在PubMed和Scopus中索引,或通过2015年至2022年的系统搜索找到。基于对国际指南的分析,发现存在许多差异和未解决的问题。寻找尿路上皮细胞癌生物标志物的理想检测方法一直是众多努力的主题。近年来,关于这一主题已经发表了广泛的非标签、实验性、新颖性和联合性方法。本综述有助于确定检测膀胱癌的准确方法,并突出未来可改进的研究领域。